國立高雄大學圖資館 |

Language: English

Back

Dermato-oncology study guideessentia...

Liu, Vincent.

Dermato-oncology study guideessential text and review /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Dermato-oncology study guideedited by Vincent Liu.
Reminder of title:	essential text and review /
other author:	Liu, Vincent.
Published:	Cham :Springer International Publishing :2021.
Description:	x, 389 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	SkinCancer.
Online resource:	https://doi.org/10.1007/978-3-030-53437-0
ISBN:	9783030534370$q(electronic bk.)

Dermato-oncology study guideessential text and review /
Dermato-oncology study guideessential text and review /[electronic resource] :edited by Vincent Liu. - Cham :Springer International Publishing :2021. - x, 389 p. :ill., digital ;24 cm.

This book provides clinicians, clinicians-in-training and researchers with a unique rapid-access educational resource on the spectrum of issues at the intersection of skin and malignancy. In it, there is clinical detail provided on how the skin reveals systemic malignancy via cutaneous metastases, genodermatoses or paraneoplastic dermatoses. At the same time, it reviews pharmacologic treatment of internal malignancy and how this can result in cutaneous adverse reactions; conversely, therapeutics for skin conditions can increase risk for internal malignancy. As arguably the most significant cutaneous malignancy, melanoma receives specific attention for its metastatic potential, current diagnostic advances, and recent therapeutic breakthroughs. Dermato-Oncology Study Guide: Essential Text and Review serves a critical educational need for clinicians caring for patients with systemic malignancy by creating an easy-to-use resource that provides practical tools to recognize skin signs of internal malignancy. Furthermore it helps in anticipating and managing adverse reactions of therapeutics for systemic malignancy, and gives the reader the opportunity to weigh the risks of malignancy of pharmacologic agents for skin disease.

ISBN: 9783030534370$q(electronic bk.)

Standard No.: 10.1007/978-3-030-53437-0doiSubjects--Topical Terms:

308878
Skin
--Cancer.

LC Class. No.: RC280.S5 / D47 2021

Dewey Class. No.: 616.99477

Dermato-oncology study guideessential text and review /
LDR:02194nmm a2200313 a 4500 001 599782
003 DE-He213
005 20210323023617.0
006 m d
007 cr nn 008maaau
008 211027s2021 sz s 0 eng d
020 $a 9783030534370$q(electronic bk.)
020 $a 9783030534363$q(paper)
024 7 $a 10.1007/978-3-030-53437-0 $2 doi
035 $a 978-3-030-53437-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.S5 $b D47 2021
072 7 $a MJK $2 bicssc
072 7 $a MED017000 $2 bisacsh
072 7 $a MJK $2 thema
082 0 4 $a 616.99477 $2 23
090 $a RC280.S5 $b D435 2021
245 0 0 $a Dermato-oncology study guide $h [electronic resource] : $b essential text and review / $c edited by Vincent Liu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a x, 389 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides clinicians, clinicians-in-training and researchers with a unique rapid-access educational resource on the spectrum of issues at the intersection of skin and malignancy. In it, there is clinical detail provided on how the skin reveals systemic malignancy via cutaneous metastases, genodermatoses or paraneoplastic dermatoses. At the same time, it reviews pharmacologic treatment of internal malignancy and how this can result in cutaneous adverse reactions; conversely, therapeutics for skin conditions can increase risk for internal malignancy. As arguably the most significant cutaneous malignancy, melanoma receives specific attention for its metastatic potential, current diagnostic advances, and recent therapeutic breakthroughs. Dermato-Oncology Study Guide: Essential Text and Review serves a critical educational need for clinicians caring for patients with systemic malignancy by creating an easy-to-use resource that provides practical tools to recognize skin signs of internal malignancy. Furthermore it helps in anticipating and managing adverse reactions of therapeutics for systemic malignancy, and gives the reader the opportunity to weigh the risks of malignancy of pharmacologic agents for skin disease.
650 0 $a Skin $x Cancer. $3 308878
650 0 $a Cancer $x Treatment $x Complications. $3 492440
650 0 $a Cutaneous manifestations of general diseases. $3 338964
650 1 4 $a Dermatology. $3 274951
650 2 4 $a Oncology. $3 195181
650 2 4 $a Pharmacotherapy. $3 615025
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Liu, Vincent. $3 383221
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-53437-0
950 $a Medicine (SpringerNature-11650)